Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.4/L11: medical device reports filed with FDA

2,565 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,565
device reports naming the brand
0% of all MAUDE reports · about 362 a year
234
reports, 12 months to August 2026
287 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,565 reports that name the brand "XiVE S plus Impl D3.4/L11" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

234 reports arrived in the 12 months to August 2026, down 18% from 287 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (38.1%), osseointegration problem (34.2%) and loss of osseointegration (20.6%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03161Sep 2021: 18Oct 2021: 41Nov 2021: 34Dec 2021: 502022Jan 2022: 50Feb 2022: 46Mar 2022: 44Apr 2022: 48May 2022: 61Jun 2022: 52Jul 2022: 49Aug 2022: 36Sep 2022: 33Oct 2022: 31Nov 2022: 39Dec 2022: 432023Jan 2023: 35Feb 2023: 43Mar 2023: 47Apr 2023: 43May 2023: 36Jun 2023: 44Jul 2023: 34Aug 2023: 22Sep 2023: 44Oct 2023: 39Nov 2023: 41Dec 2023: 292024Jan 2024: 33Feb 2024: 49Mar 2024: 25Apr 2024: 43May 2024: 35Jun 2024: 31Jul 2024: 27Aug 2024: 35Sep 2024: 17Oct 2024: 37Nov 2024: 23Dec 2024: 112025Jan 2025: 23Feb 2025: 25Mar 2025: 40Apr 2025: 10May 2025: 19Jun 2025: 21Jul 2025: 31Aug 2025: 30Sep 2025: 39Oct 2025: 15Nov 2025: 23Dec 2025: 152026Jan 2026: 30Feb 2026: 20Mar 2026: 10Apr 2026: 13May 2026: 15Jun 2026: 19Jul 2026: 12Aug 2026: 23

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03577132019: 6420192021: 71320212022: 53220222023: 45720232024: 36620242025: 29120252026: 1422026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%2,563
Malfunction0.1%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,565
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate97738.1%62.8%
Osseointegration problem87834.2%7.7%
Loss of osseointegration52920.6%22.4%
Fracturea broken bone1837.1%1.6%
Off-label use30.1%0%
Loosening of implant not related to bone-ingrowth20.1%0.1%
Improper or incorrect procedure or method10%0%
Insufficient device problem information10%0.2%
Malposition of device10%0.1%
Mechanical problema mechanical problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,564100%
Inflammationinflammation30912%
Osteolysis1415.5%
Pocket erosion1204.7%
Inadequate osseointegration50.2%
Painpain, site not specified30.1%
Deformity/ disfigurement10%
Fistula10%
Implant pain10%
Laceration(s)10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.4/L11Product code DZEAll MAUDE reports
Reports2,5653,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.4/L11 reports

How many FDA reports name XiVE S plus Impl D3.4/L11?

2,565 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 234 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (38.1%), osseointegration problem (34.2%), loss of osseointegration (20.6%), fracture (7.1%) and off-label use (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.4/L11 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.